PROtective ventilation with high versus low PEEP during one-lung ventilation for THORacic surgery
PROTHOR: A randomized controlled trial
User Tools
Sidebar
200:CfCenters
Table of Contents
Call for Centers
The PROTHOR Trial is open for participation. For each country a designated person will coordinate on a national Level. If you want to participate in this trial and don't know your national coordinator's name, please contact Thomas Kiss (prothor@peg-dresden.de)
Steering Committee:
- G. Cinella, Foggia, Italy
- E. Cohen, New York, USA
- M. El Tahan, Dammam, Saudi Arabia
- L.F. Falcão, São Paulo, Brazil
- C. Gregoretti, Turin, Italy
- M. Granell, Valencia, Spain
- M. Gama de Abreu, Dresden, Germany
- T. Hachenberg, Magdeburg, Germany
- M. Hollmann, Amsterdam, The Netherlands
- R.Jankovic, Niš, Serbia
- W. Karzai, Bad Berka, Germany
- J. Krassler, Coswig/Saxonia, Germany
- T. Kiss, Dresden, Germany
- T. Loop, Freiburg, Germany
- M-J, Licker, Geneva, Switzerland
- N. Marczin, London, United Kingdom
- G H. Mills, Sheffield, United Kingdom
- M. T. Murrell, New York, USA
- Z. Nisnevitch-Savarese, New York, USA
- P. Pelosi, Genua, Italy
- R. Rossaint, Aachen, Germany
- M. Schultz, Amsterdam, The Netherlands
- M. Sentürk, Istanbul, Turkey
- A. Serpa Neto, São Paulo, Brazil
- P. Severgnini, Varese, Italy
- L. Szegedi, Brussels, Belgium
- T. Vegh, Debrecen, Hungary
- J. Zhong, Shanghai, China
National Coordinators:
- Turkey: Mert Sentürk & Mukadder Orhan Sungur, Istanbul
- Germany: Marcelo Gama de Abreu, Dresden; Torsten Loop, Freiburg
- Spain: Manuel Granell
- Netherlands: Markus Hollmann, Amsterdam
- United Kingdom: Gary Mills, Sheffield
- Belgium: Laszlo Szegedi, Brussels
- Italy: Paolo Pelosi, Genoa
- USA: Matthew T Murrell, New York
- Switzerland: Marc Licker, Geneva
- Brazil: Luiz Fernando Falcão, São Paulo
- Argentina: Jorge Luis Iglesias
- Serbia: Vojislava Neskovic, Belgrade; Radmilo Jankovic, Niš
- Czech Republic: Pavel Michálek, Prague
- Hungary: Tamás Végh, Debrecen
- Romania: Radu Stoica, Bucharest
- Croatia: Jasna Spicek, Zagreb
Become a CoAuthor
PROTHOR is an investigator-initiated study, there won't be any paying for patients inclusion to the centers. A co-authorship is granted for every 20 randomized patients. Furthermore, each center may run their own sub-study upon application to the PROTHOR steering committee.
Trial registration
The trial has been registered at clinicaltrials.gov with trial . ID NCT02963025
Actively participating centers
- 001 Istanbul, Turkey
- 002 Dresden, Germany
- 003 Magdeburg, Germany (pending ethics approval)
- 004 Coswig, Germany
- 005 Münster, Germany
- 006 NYC Cornell Medical College, USA
- 007 LMU München, Germany
- 008 Hospital General Universitario de Valencia, Spain
- 009 Freiburg, Germany
- 010 Insular Hospital, Gran Canaria, Spain
- 011 Academic Medical Center Amsterdam, The Netherlands
- 012 Uniklinikum Aachen, Germany
- 013 Hospital Álvaro Cunqueiro, Vigo, Spain
- 014 University Hospital Centre Zagreb, Croatia
- 015 “Sotiria” Chest Hospital, Athens, Greece
- 016 Institutul de Pneumoftiziologie “Marius Nasta” Bucharest, Romania
- 017 Military Medical Academy, Belgrade, Serbia (i)
- 018 Hospital Universitario de La Ribera, Valencia, Spain
- 019 Ospedale Policlinico San Martino, Genova, Italy
- 020 General University Hospital, Prague, Czech Republic (i)
- 021 University Hospital Clínic de Barcelona, Spain
- 022 Central Military Emergency University Hospital Bucharest
- 023 Radboud University Medical Centre Nijmegen, The Netherlands
- 024 Attikon University Hospital, Athens, Greece
- 025 University Medical Centre Ljubljana, Slovenia
- 026 OORR Foggia, University of Foggia, Italy
- 027 HOSPITAL MARIE LANNELONGUE, France
- 028 Merheim Hospital, Cologne, Germany
- 029 University Hospital of Heraklion
- 030 Fudan University, Shanghai Cancer Center, Shanghai, China
- 031 Arcispedale Sant'Anna, Ferrara, Italy
200/CfCenters.txt · Last modified: 2018/07/18 09:23 by admin
Page Tools
